PDZ domains are abundant protein interaction modules and typically recognize a short motif at the C terminus of their ligands, with a few residues in the motif endowing the binding specificity. The sequence-based rules, however, cannot fully account for the specificity between the vast number of PDZ domains and ligands in the cell. Plexins are transmembrane receptors that regulate processes such as axon guidance and angiogenesis. Two related guanine nucleotide exchange factors (GEFs), PDZ-RhoGEF and leukemiaassociated RhoGEF (LARG), use their PDZ domains to bind class B plexins and play critical roles in signaling. Here, we present the crystal structure of the full-length cytoplasmic region of PlexinB2 in complex with the PDZ domain of PDZ-RhoGEF. The structure reveals that, in addition to the canonical C-terminal motif/PDZ interaction, the 3D domain of PlexinB2 forms a secondary interface with the PDZ domain. Our biophysical and cell-based assays show that the secondary interface contributes to the specific interaction between plexin and PDZ-RhoGEF and to signaling by plexin in the cell. Formation of secondary interfaces may be a general mechanism for increasing affinity and specificity of modular domain-mediated interactions.
PDZ domains are abundant protein interaction modules and typically recognize a short motif at the C terminus of their ligands, with a few residues in the motif endowing the binding specificity. The sequence-based rules, however, cannot fully account for the specificity between the vast number of PDZ domains and ligands in the cell. Plexins are transmembrane receptors that regulate processes such as axon guidance and angiogenesis. Two related guanine nucleotide exchange factors (GEFs), PDZ-RhoGEF and leukemiaassociated RhoGEF (LARG), use their PDZ domains to bind class B plexins and play critical roles in signaling. Here, we present the crystal structure of the full-length cytoplasmic region of PlexinB2 in complex with the PDZ domain of PDZ-RhoGEF. The structure reveals that, in addition to the canonical C-terminal motif/PDZ interaction, the 3D domain of PlexinB2 forms a secondary interface with the PDZ domain. Our biophysical and cell-based assays show that the secondary interface contributes to the specific interaction between plexin and PDZ-RhoGEF and to signaling by plexin in the cell. Formation of secondary interfaces may be a general mechanism for increasing affinity and specificity of modular domain-mediated interactions.
PDZ | plexin | signaling | protein interaction module | specificity P lexins are cell surface receptors for semaphorins, extracellular cues that control essential processes such as neuronal axon guidance and vasculature development (1) . Binding of semaphorin to the extracellular region of plexin induces formation of the active dimer of the cytoplasmic region, which transduces signal to downstream pathways (2) (3) (4) (5) (6) (7) . The plexin cytoplasmic region contains a juxtamembrane segment (JM-segment), a RhoGTPase binding domain (RBD), and a GTPase activating protein (GAP) domain (8) (9) (10) . The GAP domain, activated by the dimerization, transduces signal through converting its substrate GTPase Rap from the GTP-bound active to the GDP-bound inactive state (2, 3) . The RBD regulates plexin activity in response to binding of Rho family GTPases, such as Rac1 (reviewed in ref. 11) .
In addition to the common signaling pathways through the domains shared by all plexins, class B plexins (B1, B2, and B3) mediate a pathway through their unique C terminus. The conserved "VTDL" motif at the C terminus of these plexins binds to the N-terminal PDZ (PSD-95/Discs-large/ZO-1) domains of two related guanine nucleotide exchange factors (GEFs), PDZ-RhoGEF, and leukemia-associated RhoGEF (LARG) (12) (13) (14) (15) (16) (17) . This interaction recruits PDZ-RhoGEF and LARG to the plasma membrane, where they promote the exchange of GDP for GTP on RhoA. GTP-bound RhoA binds its downstream effectors and contributes to plexin signaling (13) (14) (15) 18) . A recent study has shown that deletion of the C terminus of PlexinB2 causes defects in the development of the liver vasculature in mice, highlighting the critical role of the PDZ-RhoGEF/LARG-RhoA pathway in plexin function in vivo (19) .
More than 250 PDZ domains exist in the human proteome, constituting one of the most abundant protein interaction modules (20, 21) . Correspondingly, there are ∼600 ligands for the PDZ domains (22) . A high degree of mutual specificity is expected between PDZ domains and their respective ligands to ensure fidelity of signaling in the cell. The fold of PDZ domains is composed of a six-stranded β-barrel and two α-helices. The canonical interaction mode between the PDZ domains and their ligands involves the binding of the C terminus of the ligand in an extended β-strand conformation to the groove between βB and αB in the PDZ domain. The C-terminal carboxyl group of the ligand forms two hydrogen bonds with the backbone of the conserved "GΦGF" motif (Φ: hydrophobic residue) in the βA-βB loop of the PDZ domain, which underlies the strong preference of PDZ domains for C termini. Previous studies have established the general rules of ligand specificity for PDZ domains (23) . Class I PDZ domains recognize C-terminal motifs with the "T/S-X-Φ" (X: any residue) sequence, whereas class II PDZ domains prefer the "Φ-X-Φ" sequence. The structural basis for this selectivity is relatively well understood (20) . However, many PDZ domains are promiscuous toward short peptidic ligands and defy these simple rules of specificity. Particularly, the PDZ domains in PDZ-RhoGEF and LARG, categorized as class I PDZ domains, bind with similar affinities to many peptides of both classes I and II (24) .
Binding of PDZ-RhoGEF and LARG to full-length class B plexins has been detected by various in vitro and cell-based experiments, whereas many other PDZ domains showed no binding under similar conditions (12) (13) (14) (15) (16) . In contrast, isolated C-terminal peptides from class B plexins and the PDZ domains of PDZRhoGEF/LARG only exhibit modest affinity, with the dissociation constant (K d ) in the range of 10-40 μM (24) (25) (26) . This Significance Protein interactions mediated by modular domains, such as PDZ and SH2 domains, play critical roles in biology. The modules typically recognize a linear motif in their ligands, with a few residues in the motif determining the specificity. We report a crystal structure of the complex between the cytoplasmic region of PlexinB2 and the PDZ domain of PDZ-RhoGEF. The structure shows that, in addition to the PDZ/motif interaction, a secondary interface is formed between the three-dimensional domains of the two proteins. We further show that the secondary interface enhances the affinity between plexin and PDZ-RhoGEF and is important for plexin signaling. Our analyses suggest that secondary interface-mediated interactions may be a broadly used mechanism for modular domains to achieve high specificity.
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This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1508931112/-/DCSupplemental. discrepancy suggests that the specificity between class B plexins and PDZ-RhoGEF/LARG is not fully recapitulated by the peptide/ PDZ interaction. More broadly, the sequence-based rules described above are likely an oversimplification of the mechanisms underlying specificity between PDZ domains and their ligands. Most previous structural and binding analyses focused on isolated peptidic binding motifs derived from PDZ ligands, leaving open the question of whether other regions in the ligands are involved in the interaction.
To address these questions, we determined the crystal structure of the complex between the full-length cytoplasmic region of PlexinB2 and the PDZ domain of PDZ-RhoGEF. The structure reveals a secondary interface between PlexinB2 and the PDZ domain, in addition to the canonical interaction mediated by the C-terminal "VTDL" motif of PlexinB2. Our structure-based mutational analyses show that the secondary interface plays an important role in the specific interaction between class B plexins and PDZ-RhoGEF.
Results
Crystal Structure of the PlexinB2/PDZ Complex Reveals a Secondary Binding Interface. We determined the crystal structure of the fulllength cytoplasmic region of mouse PlexinB2 (PlexinB2 cyto ) in complex with the PDZ domain from human PDZ-RhoGEF (Fig. 1A) . The diffraction data are anisotropic, extending to 3.2-Å resolution in the a* and b* directions and ∼5 Å resolution in the c* direction (Table S1 ). The asymmetric unit of the crystal contains one PlexinB2/PDZ complex (Fig. S1 ). The structure of PlexinB2 cyto , except for the disordered JM-segment, is similar to reported structures of other plexins (2, 3, (8) (9) (10) . The PDZ domain here is similar to the NMR structure of the PDZ domain of LARG (Fig. S2 ). PlexinB2 cyto and the PDZ domain form a 1:1 complex, with the PlexinB2 "VTDL" motif and the PDZ domain interacting in the typical PDZ/type I ligand binding mode ( Fig. 1 B and C). These interactions are similar to those seen in the NMR structure of the complex between the octameric tail peptide from PlexinB1 and the PDZ domain from LARG ( Fig. 1 B and C and Fig. S2 ) (25) . In addition, Lys-1838 in PlexinB2, immediately upstream of the VTDL motif, makes an electrostatic contact with Asp-64 in the PDZ domain (Fig. 1C) . The equivalent interaction, between Lys-2131 in the human PlexinB1 peptide and Asp-89 in the LARG PDZ domain, is also present in the NMR structure ( Fig. S2) (25) . Similar interactions have been extensively characterized for many PDZ domains and their ligands (20) .
In addition to the canonical interface, our structure shows a secondary interface between the last two helices in the GAP domain of PlexinB2 and one face of the PDZ domain composed of β strands B-D (Fig. 2A) . The two interfaces together bury ∼1,500 Å 2 of solvent-accessible surface area, with the canonical and the secondary interfaces contributing ∼600 and ∼900 Å 2 , respectively. The center of the secondary interface is mediated by hydrophobic interactions between Leu-68 from the PDZ domain and two alanine residues (Ala-1832 and -1833) from PlexinB2 ( Fig. 2A) . Ile-66 of the PDZ and Tyr-1806 of PlexinB2 contribute additional hydrophobic contacts at the periphery of the interface. The interface is further stabilized by polar interactions. Arg-88 and Asp-64 from the PDZ domain interact with Asp-1807 and Lys-1838 from PlexinB2 cyto , respectively (Fig. 2B) . Tandem glutamine residues from PlexinB2 (Gln-1829 and -1830) interact with the backbone carbonyls of Gly-86 and Asp-87 from the PDZ domain. Ser-62 and Gln-70 from the PDZ domain make polar interactions with the C terminus of the last helix in the PlexinB2 GAP domain (Fig. 2B) . Some of these interactions may be mediated by hydrogen bonds, but are not assigned because of the moderate resolution of the structure.
The residues in PlexinB2 mediating the secondary interface are conserved across class B plexins, but not among class A, C, and D plexins (Fig. 2C) . Ile-66 and Leu-68 in the PDZ domain of PDZ-RhoGEF are replaced by a proline and phenylalanine residue, respectively, in LARG, maintaining the hydrophobicity (Fig. 2D ). Other residues in the secondary interface are identical between PDZ-RhoGEF and LARG from both human and mouse (Fig. 2D ). These residues, however, are not conserved in PDZ domains from other proteins (Fig. 2D ). These patterns of sequence conservation suggest that class B plexins and PDZRhoGEF/LARG have coevolved the secondary interface to enhance their mutual specificity, and the secondary interface is functionally important.
Tight Binding Between PlexinB2 cyto and the PDZ Domain from PDZRhoGEF. By using fluorescence-based methods or isothermal titration calorimetry (ITC), several studies have determined the K d value between isolated C-terminal peptides from PlexinB1 and the PDZ domain of PDZ-RhoGEF in the range of 30-36 μM under various buffer conditions (24, 26) . The PDZ domain of LARG shows similar affinity to the tail peptide from PlexinB1 (24) (25) (26) . The peptides used in the studies of PDZ-RhoGEF included no more than the C-terminal six residues of human PlexinB1, which are identical to those in mouse PlexinB2. We analyzed the binding between PlexinB2 cyto and the PDZ domain of PDZ-RhoGEF using ITC. PlexinB2 cyto with the C-terminal four residues truncated (ΔVTDL) showed no detectable binding to the PDZ domain, consistent with the notion that the VTDL motif is critical for the interaction (Fig. 3) . PlexinB2 cyto binds the PDZ domain with a (Fig. 3) , >10-fold tighter than that of the isolated C-terminal motif. These results suggest that the secondary interface as observed in our crystal structure substantially enhances the plexin/PDZ interaction.
Mutational Analyses of the Secondary Interface. To assess the contribution of the secondary interface to the plexin/PDZ interaction, we examined the effects of a series of mutations at this interface by ITC. Three mutations-Y1806A, A1832E, and A1833E-were introduced individually into PlexinB2 cyto . The Y1806A mutant displayed approximately twofold reduction in binding (K d = 3.7 μM) compared with the wild-type (WT) PlexinB2 cyto (Fig. 3) . The A1832E and A1833E mutants showed much weaker binding, with K d values of 13 and 30 μM, respectively. The A1833E mutation reduces the affinity to the reported level of the isolated C-terminal peptide of PlexinB1, effectively eliminating the contribution of the secondary interface. Tyr-1806 is located at the periphery of the interface, and the alanine mutation removes a portion of the hydrophobic interaction, but does not sterically occlude binding. Introducing a charged and larger residue to the hydrophobic core of the interface, as in the case of the A1832E and A1833E mutations, however, disrupts the secondary interface. The PDZ mutations also attenuated binding to various degrees, consistent with the features of the secondary interface. The PDZ R88A mutant increased K d by approximately threefold to 6.4 μM (Fig. 3) . Loss of the peripheral interaction between Arg-88 in the PDZ domain and Asp-1807 in PlexinB2 cyto is not expected to actively disrupt the interface core or the ability of other contacts to form. The R88E mutation, which introduces charge/charge repulsion with Asp-1807 in PlexinB2 cyto , reduced the affinity by 20-fold (K d = 40 μM). An alanine mutation of Leu-68 in the PDZ domain, which docks into the hydrophobic patch created by Ala-1832 and -1833 in PlexinB2 cyto , reduces the affinity by approximately fivefold. Mutating a peripheral hydrophobic residue in the PDZ domain, I66A, attenuated binding by less than twofold. Together, these data demonstrate that the secondary interface is responsible for the >10-fold tighter binding to the PDZ domain by PlexinB2 cyto compared with the isolated PDZ-binding motif.
Both Binding Interfaces Contribute to Recruitment of PDZ-RhoGEF by
Plexin. We have shown previously that the GEF activity of PDZRhoGEF and its homologs can be facilitated by membrane recruitment to membrane-delimited substrates such as RhoA (27) and that this functional recruitment can mediate hormone signaling in cells (28) . In the reconstituted system, GEFs were recruited to the surface of lipid vesicles that contained regulatory partners and substrates tethered to the membrane surface through interaction of polyhistidine tags with Ni-NTA-conjugated lipids. We used this system to examine the interaction of fulllength PDZ-RhoGEF with PlexinB2 cyto (Fig. 4 A-C) . PDZRhoGEF in solution displayed modest nucleotide exchange activity toward RhoA tethered to lipid vesicles. Addition of His 6 -PlexinB2 cyto produced a concentration-dependent increase in the exchange activity (Fig. 4 A and B) , suggesting functional recruitment of PDZ-RhoGEF by His 6 -PlexinB2 cyto to membranelocalized RhoA. Deletion of the C-terminal motif from PlexinB2 (ΔVTDL) eliminated the GEF activity increase (Fig. 4 B and C) , consistent with an anticipated reduction in the recruitment. We further tested mutations in the secondary interface, two in the PDZ domain (R88E and R88A) and two in PlexinB2 cyto (A1832E and A1833E). All four mutants attenuated the stimulatory effect of PlexinB2 on the GEF activity of PDZRhoGEF (Fig. 4C) . The partial reduction by the R88A mutation is consistent with its more moderate effect on binding affinity (Fig. 3) . These results implicate both the primary and secondary interfaces in the recruitment of PDZ-RhoGEF by plexin. The sufficiency of this interaction is demonstrated by the recruitment of a chimeric protein containing the PDZ domain of PDZRhoGEF linked to an unrelated RacGEF, TRIO (triple functional domain protein) (Fig. 4D) . His 6 -PlexinB2 cyto stimulates nucleotide exchange of membrane delimited Rac1 by the chimeric PDZ-TRIO, but not TRIO alone.
Secondary Interface Contributes to Plexin-Mediated Activation of PDZRhoGEF in Cells. Activation of class B plexins by semaphorin activates PDZ-RhoGEF and LARG, leading to increased levels of GTP-bound RhoA in cells (12) (13) (14) (15) (16) (17) . To examine whether this plexin/ PDZ-RhoGEF-mediated activation of RhoA is dependent on the secondary interface, we used a pull-down assay for quantifying RhoA(GTP) levels in the cell (29) . Full-length human PlexinB1, which is nearly identical to mouse PlexinB2 in both the C-terminal motif and the secondary interface, was used in these experiments. Consistent with previous studies, the results show that overexpression of PlexinB1 increased the levels of RhoA(GTP) in HEK293T cells, which express PDZ-RhoGEF endogenously (Fig. 5) (13, 18) . RhoA activation was further enhanced by semaphorin treatment. Deletion of the VTDL motif in PlexinB1 (ΔVTDL) abolished RhoA activation in the presence or absence of semaphorin treatment. These results are also consistent with previous studies (13, 14) . We then tested the effects on RhoA activation of the A2125E and A2126E mutations of PlexinB1, equivalent to the secondary interface mutations A1832E and A1833E of PlexinB2, respectively. These mutations both attenuated RhoA activation, although the reduction was not as severe as that caused by ΔVTDL (Fig. 5) . Together, our data strongly support the hypothesis that the C-terminal motif and secondary interface in class B plexins together contribute to optimal recruitment of PDZ-RhoGEF and activation of RhoA for signal transduction in the cell.
Discussion
Protein interactions between modular domains, such as PDZ, SH2, and SH3 domains, and linear binding motifs are a common theme in biology (30) . An established paradigm is that sequence variations of one or a few residues in the binding motifs determine the specificity. However, modules of the same type often show similar sequence preferences for the binding motifs, and similar or identical motifs often exist in different proteins. This paradigm is therefore inadequate for rationalizing the diverse yet specific interactions mediated by modular domains. In the case of PDZ domains, binding motifs of different classes do not always show large differences in affinity to cross-typed PDZ domains. Extensive investigations, including large-scale peptide library screening and bioinformatics analyses, have shown that residues beyond positions 0 and −2 in PDZ binding motifs are involved in fine-tuning the specificity (20, 21) . Based on these studies, as many as 16 classes have been defined to account for the specificity profiles of PDZ domains (31) . A recent study has shown that the PDZ domain in the protein PALS1 forms a structural supramodule with the SH3 and guanylate kinase domains, with all of the three domains collectively contributing to specific binding to the C terminus of its ligand crumbs (32) .
The above analyses are largely limited to linear binding motifs. Our finding of the secondary interface mediated by the folded domains of PlexinB2 and PDZ-RhoGEF provides an additional dimension to the mechanism by which PDZ domains achieve specificity. Interestingly, a recent study has shown that the C-terminal SH2 domain in phospholipase Cγ forms a secondary interface with the kinase domain of fibroblast growth factor receptor, in addition to the SH2/phosphoryl-peptide interaction (33) . Similar secondary interactions have also been seen for a SH3 domain and a small GTPase (34, 35) . The 3D domain-mediated secondary interfaces may be broadly used by modular domains to increase affinity and specificity, but are underappreciated because they involve residues not adjacent in sequence to the binding motifs and cannot be easily identified by sequence analyses. Structural studies of larger constructs beyond the modules and their binding motifs are required to reveal such interactions.
It is unclear how the interaction between class B plexins and PDZ-RhoGEF/LARG is regulated by semaphorin binding to plexin. Before activation, plexin exists as an inactive monomer or inhibitory dimer (3, 9, 36) . Semaphorin binding induces the formation of the active dimer of plexin (2, (4) (5) (6) (7) . PDZ-RhoGEF and LARG also form dimers or oligomers through their C-terminal coiled-coil region (37) . The plexin active dimer and the PDZ-Rho-GEF/LARG dimer may form a 2:2 complex (Fig. S3A) . Alternatively, dimeric PDZ-RhoGEF/LARG may bridge two copies of the plexin dimer, leading to their clustering on the cell surface (Fig. S3B) . The dimerization/oligomerization may increase the avidity between plexin and PDZ-RhoGEF/LARG. PDZ-RhoGEF and LARG both have other domains that help target them to the plasma membrane, such as the Pleckstrin-homology domain that interacts with GTP-bound RhoA (38) . These factors together may facilitate the interaction between plexin and PDZ-RhoGEF/LARG and thereby enhance their ability to discriminate against nonspecific interactions.
Materials and Methods
Full-length PDZ-RhoGEF was expressed in Spodoptera frugiperda cells. Other proteins were expressed in Escherichia coli. Proteins were purified by affinity chromatography in combination with ion exchange and gel filtration chromatography. Detailed experimental procedures are included in SI Materials and Methods.
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